Is it true that kids are not being included in the current COVID-19 vaccine Phase 3 trials?
Families/Kids Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
Q: What does that mean for when my kid can get vaccinated? A: It is true: Current Phase 3 trials do not include children, and it means we’ve got a longer wait for a vaccine approved for use in children. We’ve covered a lot of vaccine development news on Dear Pandemic (see links below), but Read more…
Lottsa Vaccine Questions Answered
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
Q: How much longer until there’s a $#&^#% vaccine?!?! Q: How do vaccine trials work, by the way? Q: Once there’s a vaccine, the pandemic is over, right? Q: How will I know if it’s safe to get the vaccine? Q: What about that AstraZeneca trial that was stopped? A: Lotsa vaccine questions! Answers below. Read more…
Dear Pandemic COVID Q&A
Families/Kids Socializing Staying Safe Vaccines Videos
Malia Jones, PhD MPH
Dear Pandemic: Q&A Live Dr. Leininger and Dr. Jones answer follower questions! Link to original FB post
Update on Herd Immunity
Biology/Immunity Infection and Spread Vaccines
Jennifer Beam Dowd, PhD
Update: We know there is on-going chatter about herd immunity. We are re-posting the explainer below, as little has changed as far as the assumptions for what it would take to achieve “natural” herd immunity. TL;DR: it’s bleak. Even at a theoretically lower threshold (50% vs 70%), the expected number of deaths is devastating. So Read more…
Did the CDC just say there would be a vaccine ready on November 1?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: Nope, but they did make some requests to state public health officials that have a lot of folks reading the vaccine tea leaves. So what actually went down? On August 27, Dr. Robert Redfield, Director of the CDC, sent a letter to state governors asking that they expedite requests from McKesson Corporation for permits Read more…
Vaccines and the Immune System
Vaccines Videos
Ashley Ritter, APRN, PhD
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity Vaccines
Ashley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
Q: What does that mean for when my kid can get vaccinated? A: It is true: Current Phase 3 trials do not include children, and it means we’ve got a longer wait for a vaccine approved for use in children. We’ve covered a lot of vaccine development news on Dear Pandemic (see links below), but Read more…
Lottsa Vaccine Questions Answered
VaccinesAlison Buttenheim, PhD MBA, Co-founder & Advisor
Q: How much longer until there’s a $#&^#% vaccine?!?! Q: How do vaccine trials work, by the way? Q: Once there’s a vaccine, the pandemic is over, right? Q: How will I know if it’s safe to get the vaccine? Q: What about that AstraZeneca trial that was stopped? A: Lotsa vaccine questions! Answers below. Read more…
Dear Pandemic COVID Q&A
Families/Kids Socializing Staying Safe Vaccines Videos
Malia Jones, PhD MPH
Dear Pandemic: Q&A Live Dr. Leininger and Dr. Jones answer follower questions! Link to original FB post
Update on Herd Immunity
Biology/Immunity Infection and Spread Vaccines
Jennifer Beam Dowd, PhD
Update: We know there is on-going chatter about herd immunity. We are re-posting the explainer below, as little has changed as far as the assumptions for what it would take to achieve “natural” herd immunity. TL;DR: it’s bleak. Even at a theoretically lower threshold (50% vs 70%), the expected number of deaths is devastating. So Read more…
Did the CDC just say there would be a vaccine ready on November 1?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: Nope, but they did make some requests to state public health officials that have a lot of folks reading the vaccine tea leaves. So what actually went down? On August 27, Dr. Robert Redfield, Director of the CDC, sent a letter to state governors asking that they expedite requests from McKesson Corporation for permits Read more…
Vaccines and the Immune System
Vaccines Videos
Ashley Ritter, APRN, PhD
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity Vaccines
Ashley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
Q: How much longer until there’s a $#&^#% vaccine?!?! Q: How do vaccine trials work, by the way? Q: Once there’s a vaccine, the pandemic is over, right? Q: How will I know if it’s safe to get the vaccine? Q: What about that AstraZeneca trial that was stopped? A: Lotsa vaccine questions! Answers below. Read more…
Dear Pandemic COVID Q&A
Families/Kids Socializing Staying Safe Vaccines VideosMalia Jones, PhD MPH
Dear Pandemic: Q&A Live Dr. Leininger and Dr. Jones answer follower questions! Link to original FB post
Update on Herd Immunity
Biology/Immunity Infection and Spread Vaccines
Jennifer Beam Dowd, PhD
Update: We know there is on-going chatter about herd immunity. We are re-posting the explainer below, as little has changed as far as the assumptions for what it would take to achieve “natural” herd immunity. TL;DR: it’s bleak. Even at a theoretically lower threshold (50% vs 70%), the expected number of deaths is devastating. So Read more…
Did the CDC just say there would be a vaccine ready on November 1?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: Nope, but they did make some requests to state public health officials that have a lot of folks reading the vaccine tea leaves. So what actually went down? On August 27, Dr. Robert Redfield, Director of the CDC, sent a letter to state governors asking that they expedite requests from McKesson Corporation for permits Read more…
Vaccines and the Immune System
Vaccines Videos
Ashley Ritter, APRN, PhD
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity Vaccines
Ashley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
Dear Pandemic: Q&A Live Dr. Leininger and Dr. Jones answer follower questions! Link to original FB post
Update on Herd Immunity
Biology/Immunity Infection and Spread VaccinesJennifer Beam Dowd, PhD
Update: We know there is on-going chatter about herd immunity. We are re-posting the explainer below, as little has changed as far as the assumptions for what it would take to achieve “natural” herd immunity. TL;DR: it’s bleak. Even at a theoretically lower threshold (50% vs 70%), the expected number of deaths is devastating. So Read more…
Did the CDC just say there would be a vaccine ready on November 1?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: Nope, but they did make some requests to state public health officials that have a lot of folks reading the vaccine tea leaves. So what actually went down? On August 27, Dr. Robert Redfield, Director of the CDC, sent a letter to state governors asking that they expedite requests from McKesson Corporation for permits Read more…
Vaccines and the Immune System
Vaccines Videos
Ashley Ritter, APRN, PhD
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity Vaccines
Ashley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
Update: We know there is on-going chatter about herd immunity. We are re-posting the explainer below, as little has changed as far as the assumptions for what it would take to achieve “natural” herd immunity. TL;DR: it’s bleak. Even at a theoretically lower threshold (50% vs 70%), the expected number of deaths is devastating. So Read more…
Did the CDC just say there would be a vaccine ready on November 1?
VaccinesAlison Buttenheim, PhD MBA, Co-founder & Advisor
A: Nope, but they did make some requests to state public health officials that have a lot of folks reading the vaccine tea leaves. So what actually went down? On August 27, Dr. Robert Redfield, Director of the CDC, sent a letter to state governors asking that they expedite requests from McKesson Corporation for permits Read more…
Vaccines and the Immune System
Vaccines Videos
Ashley Ritter, APRN, PhD
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity Vaccines
Ashley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: Nope, but they did make some requests to state public health officials that have a lot of folks reading the vaccine tea leaves. So what actually went down? On August 27, Dr. Robert Redfield, Director of the CDC, sent a letter to state governors asking that they expedite requests from McKesson Corporation for permits Read more…
Vaccines and the Immune System
Vaccines VideosAshley Ritter, APRN, PhD
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity Vaccines
Ashley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
Q: How does a vaccine work? What viruses are particularly difficult to design a vaccine for? A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that Read more…
How does a vaccine work? What viruses are particularly difficult to design a vaccine for?
Biology/Immunity VaccinesAshley Ritter, APRN, PhD
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
Vaccines
Alison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: Thank you for this GREAT question from an awesome 6-year old follower. A vaccine takes a dead or very weak virus and introduces it to the body to trick your immune system into building an immune response that protects you. Viruses have antigens that work sort of like a name tag. When your body Read more…
I’d like to be a “guinea pig” for a COVID-19 vaccine Phase 3 clinical trial. Can I volunteer to do that?
VaccinesAlison Buttenheim, PhD MBA, Co-founder & Advisor
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: You sure can! In the United States, the COVID-19 Prevention Network (CoVPN) Volunteer Screening Registry is open and accepting volunteers for Phase 3 clinical trials (link below). You’ll answer about 25 questions (it took this Nerdy Girl fewer than 10 minutes to complete the screening survey) and then your information will be available to Read more…
Wait, WHAT?! Russia already approved a COVID-19 vaccine?
VaccinesJennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity VaccinesJennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
VaccinesLindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity VaccinesJennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
VaccinesLindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe VaccinesMalia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines VideosMalia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments VaccinesLindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity VaccinesMalia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
VaccinesLindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
